JRCT ID: jRCT2080223547
Registered date:30/05/2017
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 25/07/2017 |
Target sample size | 30 |
Countries of recruitment | Japan,North America,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Neladenoson bialanate Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety efficacy exploratory pharmacodynamics |
---|---|
Secondary Outcome | pharmacokinetics other |
Key inclusion & exclusion criteria
Age minimum | >= 45age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03098979,JapicCTI-173602 |
Contact
Public contact | |
Name | |
Address | |
Telephone | - |
byl_ct_contact@bayer.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | - |
byl_ct_contact@bayer.com | |
Affiliation |